Institutional members access full text with Ovid®

Share this article on:

Recombinant Human Annexin A5: A Novel Drug Candidate for Treatment of Sepsis?*

Hu, Guochang MD, PhD

doi: 10.1097/01.ccm.0000435680.21801.0f

Departments of Anesthesiology and Pharmacology, University of Illinois College of Medicine, Chicago, IL

* See also p. e32.

Dr. Hu received support for article research from the National Institutes of Health (HL 104092).

© 2014 by the Society of Critical Care Medicine and Lippincott Williams & Wilkins